Description
PT 141 (Bremelanotide) is a synthetic peptide used in preclinical studies to investigate melanocortin receptor pathways and sexual behavior modulation. Supplied as a 10 mg lyophilised vial (3 ml), it is intended for in vitro or animal research to explore sexual function, neurological pathways, and receptor pharmacology.
Key Clinical Benefits:
- Investigates sexual behavior and melanocortin receptor pathways
- Supports neurological and pharmacological research







Reviews
There are no reviews yet.